Medicine
Amlodipine and Benazepril 5 mg/10 mg capsule
Amlodipine and Benazepril 5 mg/10 mg capsule is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Amlodipine and Benazepril
- Brand
- Sold under the generic name
- Strength
- 5 mg/10 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 1000 capsules and 21 more
- Manufacturers
- Avet PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaAurobindo PharmaIndiaLupinIndiaBryant Ranch PrepackA-S Medication SolutionsRemedyrepackRising Pharma HoldingsAmneal Pharmaceuticals NYAvKARE
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 February 2010
- Identifiers
- RxCUI 898353, 898342, 898346 +3DailyMed set ID 5f05921c-4f19-3470-e063-6394a90aedd6, 13ecf91f-dce8-4262-a54a-7bef2b1591c3, 27b0c628-820a-48bf-a411-86c0ebd4cc8d +12NDC 73190-021, 70518-4499, 23155-921 +12Application ANDA077215, ANDA077183, ANDA091431 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 65862-583-01 | Aurobindo PharmaIndia | 5 September 2012 |
| 500 capsule in 1 bottle | 65862-583-05 | Aurobindo PharmaIndia | 5 September 2012 |
| 100 capsule in 1 bottle | 23155-921-01 | Avet PharmaceuticalsIndia | 23 May 2026 |
| 500 capsule in 1 bottle | 23155-921-05 | Avet PharmaceuticalsIndia | 23 May 2026 |
| 1000 capsule in 1 bottle | 23155-921-10 | Avet PharmaceuticalsIndia | 23 May 2026 |
| 100 capsule in 1 bottle | 55111-339-01 | Dr. Reddy's LaboratoriesIndia | 19 April 2010 |
| 500 capsule in 1 bottle | 55111-339-05 | Dr. Reddy's LaboratoriesIndia | 19 April 2010 |
| 30 capsule in 1 bottle | 55111-339-30 | Dr. Reddy's LaboratoriesIndia | 19 April 2010 |
| 100 capsule in 1 bottle | 68180-756-01 | LupinIndia | 5 February 2010 |
| 100 capsule in 1 bottle | 69238-2685-1 | Amneal Pharmaceuticals NY | 14 April 2026 |
| 100 capsule in 1 bottle | 57237-143-01 | Rising Pharma Holdings | 5 September 2012 |
| 500 capsule in 1 bottle | 57237-143-05 | Rising Pharma Holdings | 5 September 2012 |
| 30 capsule in 1 bottle | 50090-5404-0 | A-S Medication Solutions | 9 December 2020 |
| 30 capsule in 1 bottle | 50090-6770-0 | A-S Medication Solutions | 23 October 2023 |
| 90 capsule in 1 bottle, plastic | 70518-1928-0 | Remedyrepack | 1 March 2019 |
| 90 capsule in 1 bottle, plastic | 70518-4499-0 | Remedyrepack | 11 October 2025 |
| 100 capsule in 1 bottle | 73190-021-01 | AvKARE | 29 October 2026 |
| 100 capsule in 1 bottle | 68001-133-00 | BluePoint Laboratories | 16 July 2015 |
| 30 capsule in 1 bottle | 71335-2634-1 | Bryant Ranch Prepack | 2 June 2025 |
| 90 capsule in 1 bottle | 71335-2634-2 | Bryant Ranch Prepack | 2 June 2025 |
| 60 capsule in 1 bottle | 71335-2634-3 | Bryant Ranch Prepack | 2 June 2025 |
| 100 capsule in 1 bottle | 71335-2634-4 | Bryant Ranch Prepack | 2 June 2025 |
| 100 capsule in 1 bottle | 84677-009-01 | Golden State Medical Supply | 27 July 2026 |
| 90 capsule in 1 bottle, plastic | 72789-432-90 | PD-Rx Pharmaceuticals | 26 September 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 March 1995 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Amlodipine and Benazepril
Clinical summary
Amlodipine and Benazepril is a fixed-dose combination of an angiotensin converting enzyme inhibitor, a calcium channel blocker and a dihydropyridine calcium channel blocker. It is available as capsules for oral use. MedsAcross supplies Amlodipine and Benazepril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Amlodipine and BenazeprilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Amlodipine and Benazepril Hydrochloride prescribing information (Avet Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Amlodipine and Benazepril 5 mg/10 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.